Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
CTI BioPharma presents data from pacritinib program at ASH » 09:05
12/13/21
12/13
09:05
12/13/21
09:05
CTIC

CTI BioPharma

$1.89 /

+0.11 (+6.18%)

CTI BioPharma Corp.…

CTI BioPharma Corp. announced five scientific poster presentations on the pacritinib clinical program at the 63rd American Society of Hematology Annual Meeting & Exposition, being held as a hybrid meeting in Atlanta, Georgia, December 11-14, 2021. Pacritinib, a JAK 2/interleukin-1 receptor-associated kinase 1 inhibitor that does not inhibit JAK1, is in development for use in patients with myelofibrosis who have thrombocytopenia. Pacritinib was studied in thrombocytopenic patients in the randomized phase 3 PERSIST-2 trial, which showed pacritinib was superior to best available therapy, including ruxolitinib, based on spleen volume reduction and modified total symptom score esponse. While many patients in the BAT arm received ruxolitinib, an analysis of the comparison between pacritinib and ruxolitinib has not been previously performed. This retrospective head-to-head analysis of pacritinib versus ruxolitinib in "first-line" patients treated in PERSIST-2 showed that patients with moderate or severe thrombocytopenia were able to maintain full dose intensity with pacritinib. Pacritinib fully dosed at 400 mg/day resulted in numerically higher rates of SVR and mTSS response, and a similar safety profile compared with lower doses of ruxolitinib in "first-line" patients with cytopenic myelofibrosis, suggesting that pacritinib may address the unmet medical need of patients with cytopenic myelofibrosis who cannot tolerate full doses of JAK1/2 inhibitors, such as ruxolitinib.

ShowHide Related Items >><<
CTIC CTI BioPharma
$1.89 /

+0.11 (+6.18%)

CTIC CTI BioPharma
$1.89 /

+0.11 (+6.18%)

12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
CTIC CTI BioPharma
$1.89 /

+0.11 (+6.18%)

  • 01
    Apr
CTIC CTI BioPharma
$1.89 /

+0.11 (+6.18%)

Conference/Events
JMP Securities to hold a virtual summit » 04:55
12/07/21
12/07
04:55
12/07/21
04:55
ALLO

Allogene Therapeutics

$17.19 /

-0.45 (-2.55%)

, BCYC

Bicycle Therapeutics

$50.35 /

-2.24 (-4.26%)

, BCAB

BioAtla

$22.46 /

+0.105 (+0.47%)

, BCRX

BioCryst

$11.18 /

-0.275 (-2.40%)

, BPMC

Blueprint Medicines

$95.36 /

+1.105 (+1.17%)

, CLLS

Cellectis

$8.08 /

-0.18 (-2.18%)

, CGEN

Compugen

$4.20 /

+0.03 (+0.72%)

, CTIC

CTI BioPharma

$1.68 /

+0.075 (+4.69%)

, CUE

Cue Biopharma

$10.94 /

-0.45 (-3.95%)

, CVAC

CureVac

$40.76 /

-2.91 (-6.66%)

, DCPH

Deciphera

$8.03 /

+0.03 (+0.38%)

, EFTR

eFfector Therapeutics

$7.44 /

+1.7 (+29.62%)

, GMDA

Gamida Cell

$2.34 /

-0.015 (-0.64%)

, HOOK

Hookipa Pharma

$2.94 /

+ (+0.00%)

, INBX

Inhibrx

$36.50 /

-0.49 (-1.32%)

, IOVA

Iovance Biotherapeutics

$16.93 /

+0.37 (+2.23%)

, KURA

Kura Oncology

$12.41 /

-0.05 (-0.40%)

, MGN

Mines Management

$1.13 /

+ (+0.00%)

, MOR

MorphoSys

$9.07 /

-0.39 (-4.12%)

, NXTC

NextCure

$5.84 /

+0.1 (+1.74%)

, PTGX

Protagonist Therapeutics

$32.77 /

+0.43 (+1.33%)

, PRTA

Prothena

$44.06 /

-2.565 (-5.50%)

, SPPI

Spectrum

$1.37 /

-0.005 (-0.36%)

, SYRS

Syros Pharmaceuticals

$3.96 /

+0.39 (+10.92%)

, VOR

Vor Biopharma

$13.15 /

+0.5 (+3.95%)

Hematology & Oncology…

Hematology & Oncology Virtual Summit to be held on December 6-7.Webcast Link

ShowHide Related Items >><<
VOR Vor Biopharma
$13.15 /

+0.5 (+3.95%)

SYRS Syros Pharmaceuticals
$3.96 /

+0.39 (+10.92%)

SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

PRTA Prothena
$44.06 /

-2.565 (-5.50%)

NXTC NextCure
$5.84 /

+0.1 (+1.74%)

MOR MorphoSys
$9.07 /

-0.39 (-4.12%)

KURA Kura Oncology
$12.41 /

-0.05 (-0.40%)

IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

INBX Inhibrx
$36.50 /

-0.49 (-1.32%)

HOOK Hookipa Pharma
$2.94 /

+ (+0.00%)

GMDA Gamida Cell
$2.34 /

-0.015 (-0.64%)

EFTR eFfector Therapeutics
$7.44 /

+1.7 (+29.62%)

DCPH Deciphera
$8.03 /

+0.03 (+0.38%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

CUE Cue Biopharma
$10.94 /

-0.45 (-3.95%)

CTIC CTI BioPharma
$1.68 /

+0.075 (+4.69%)

CLLS Cellectis
$8.08 /

-0.18 (-2.18%)

CGEN Compugen
$4.20 /

+0.03 (+0.72%)

BPMC Blueprint Medicines
$95.36 /

+1.105 (+1.17%)

BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

12/03/21 Canaccord
Allogene Therapeutics clinical hold could be lifted shortly, says Canaccord
10/19/21 Cowen
Allogene Therapeutics assumed with an Outperform at Cowen
10/12/21 JMP Securities
Allogene Therapeutics price target lowered to $27 from $53 at JMP Securities
10/08/21
Fly Intel: Top five analyst downgrades
BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

10/14/21 JMP Securities
Bicycle Therapeutics price target raised to $85 from $53 at JMP Securities
10/11/21 Canaccord
Bicycle Therapeutics price target raised to $60 from $40 at Canaccord
10/08/21 Oppenheimer
Bicycle Therapeutics price target raised to $65 from $47 at Oppenheimer
10/08/21 B. Riley
Bicycle Therapeutics price target raised to $72 from $56 at B. Riley
BCAB BioAtla
$22.46 /

+0.105 (+0.47%)

10/14/21 BTIG
BioAtla assumed with a Buy at BTIG
06/28/21 Roth Capital
BioAtla initiated with a Buy at Roth Capital
05/04/21 Credit Suisse
BioAtla assumed with an Outperform at Credit Suisse
05/04/21 JPMorgan
BioAtla price target raised to $64 from $45 at JPMorgan
BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

11/22/21 Piper Sandler
BioCryst financing lifts one of two overhangs, says Piper Sandler
11/04/21 Barclays
BioCryst price target lowered to $17 from $21 at Barclays
11/03/21 Piper Sandler
BioCryst earnings pullback a buying opportunity, says Piper Sandler
08/06/21 Jefferies
BioCryst downgraded to Hold from Buy at Jefferies
BPMC Blueprint Medicines
$95.36 /

+1.105 (+1.17%)

12/01/21 Raymond James
Blueprint Medicines added to Analyst Current Favorites list at Raymond James
11/29/21 Stifel
Stifel expects neutral reaction for Blueprint acquisition of Lengo Therapeutics
11/29/21 Piper Sandler
Blueprint acquisition may surprise investors looking for buyout, says Piper
11/19/21 Morgan Stanley
Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
CLLS Cellectis
$8.08 /

-0.18 (-2.18%)

11/30/21 JMP Securities
Cellectis initiated with an Outperform at JMP Securities
11/08/21 William Blair
Cellectis downgraded to Market Perform at William Blair on slow execution
11/08/21 William Blair
Cellectis downgraded to Market Perform from Outperform at William Blair
10/08/21 Baird
Baird cuts Cellectis to Neutral after partner Allogene's clinical hold
CGEN Compugen
$4.20 /

+0.03 (+0.72%)

CTIC CTI BioPharma
$1.68 /

+0.075 (+4.69%)

12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
CUE Cue Biopharma
$10.94 /

-0.45 (-3.95%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

10/22/21
Fly Intel: Top five analyst initiations
10/22/21 Deutsche Bank
CureVac initiated with a Hold at Deutsche Bank
07/01/21 Berenberg
CureVac COVID vaccine data may be enough for EU approval, says Berenberg
06/30/21
CureVac announces COVID vaccine candidate demonstrates 48% efficacy
DCPH Deciphera
$8.03 /

+0.03 (+0.38%)

12/01/21 H.C. Wainwright
Deciphera price target lowered to $15 from $25 at H.C. Wainwright
11/30/21 Piper Sandler
Deciphera price target lowered to $11 from $14 at Piper Sandler
11/08/21 Barclays
Deciphera downgraded to Equal Weight at Barclays after GIST trial miss
11/08/21 Canaccord
Deciphera downgraded to Hold at Canaccord
EFTR eFfector Therapeutics
$7.44 /

+1.7 (+29.62%)

11/08/21 Stifel
eFfector Therapeutics upgraded to Buy at Stifel on NSCLC optimism
11/08/21 Stifel
eFfector Therapeutics upgraded to Buy from Hold at Stifel
10/12/21 Credit Suisse
eFfector Therapeutics initiated with an Outperform at Credit Suisse
10/04/21 Mizuho
eFfector Therapeutics initiated with a Buy at Mizuho
GMDA Gamida Cell
$2.34 /

-0.015 (-0.64%)

11/16/21 H.C. Wainwright
Gamida Cell price target lowered to $22 from $27 at H.C. Wainwright
11/16/21 Oppenheimer
Gamida Cell price target lowered to $15 from $17 at Oppenheimer
11/15/21 Piper Sandler
Gamida Cell price target lowered to $13 from $23 at Piper Sandler
11/01/21 Alliance Global Partners
Gamida Cell initiated with a Buy at Alliance Global Partners
HOOK Hookipa Pharma
$2.94 /

+ (+0.00%)

11/12/21 Morgan Stanley
Morgan Stanley downgrades Hookipa to Equal Weight after oncology data update
11/12/21 Morgan Stanley
Hookipa Pharma downgraded to Equal Weight from Overweight at Morgan Stanley
11/11/21 H.C. Wainwright
Hookipa Pharma price target lowered to $15 from $21 at H.C. Wainwright
11/10/21 JMP Securities
Hookipa Pharma price target lowered to $11 from $25 at JMP Securities
INBX Inhibrx
$36.50 /

-0.49 (-1.32%)

11/10/21 Credit Suisse
Inhibrx price target raised to $53 from $44 at Credit Suisse
11/02/21 JMP Securities
Inhibrx price target raised to $53 from $46 at JMP Securities
09/21/21 JMP Securities
Inhibrx initiated with an Outperform at JMP Securities
04/26/21 Credit Suisse
Inhibrx assumed with an Outperform at Credit Suisse
IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

12/06/21 Cowen
Iovance Biotherapeutics assumed with an Outperform at Cowen
11/15/21 Oppenheimer
Iovance price target lowered to $31 from $38 at Oppenheimer
11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
KURA Kura Oncology
$12.41 /

-0.05 (-0.40%)

11/26/21 Credit Suisse
Kura Oncology price target lowered to $21 from $40 at Credit Suisse
11/24/21 H.C. Wainwright
Kura Oncology price target lowered to $32 from $43 at H.C. Wainwright
05/04/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
04/26/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
MGN Mines Management
$1.13 /

+ (+0.00%)

MOR MorphoSys
$9.07 /

-0.39 (-4.12%)

11/12/21 Morgan Stanley
MorphoSys price target raised to EUR 76 from EUR 75 at Morgan Stanley
09/27/21 Citi
MorphoSys downgraded to Neutral from Buy at Citi
09/13/21 Goldman Sachs
MorphoSys reinstated with a Neutral at Goldman Sachs
09/02/21 Barclays
MorphoSys price target lowered to EUR 47 from EUR 90 at Barclays
NXTC NextCure
$5.84 /

+0.1 (+1.74%)

11/05/21 Piper Sandler
NextCure's Phase II NC318 study continuing weekly dosing, says Piper Sandler
08/08/21 Piper Sandler
NextCure price target lowered to $21 from $26 at Piper Sandler
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

11/15/21 JMP Securities
Protagonist Therapeutics price target raised to $70 from $60 at JMP Securities
11/04/21 Piper Sandler
Piper 'pleasantly surprised' by Protagonist Therapeutics' ASH abstracts
10/13/21 JMP Securities
Protagonist Therapeutics price target raised to $60 from $47 at JMP Securities
10/12/21 JPMorgan
JPMorgan upgrades Protagonist after 'rapid' clinical hold removal
PRTA Prothena
$44.06 /

-2.565 (-5.50%)

11/19/21 JMP Securities
Prothena initiated with an Outperform at JMP Securities
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
09/27/21 Oppenheimer
Prothena price target raised to $100 from $90 at Oppenheimer
09/20/21 Fox Advisors
Prothena initiated with an Overweight at Fox Advisors
SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

08/18/21 B. Riley
Spectrum price target lowered to $6 from $8 at B. Riley
06/01/21 H.C. Wainwright
H.C. Wainwright remains bullish on Spectrum as FDA inspects Rolontis facility
SYRS Syros Pharmaceuticals
$3.96 /

+0.39 (+10.92%)

09/27/21 Roth Capital
Veteran Chee coming aboard a positive for Syros, says Roth Capital
09/23/21 Roth Capital
Syros Pharmaceuticals price target raised to $23 from $20 at Roth Capital
05/06/21 Piper Sandler
Syros Pharmaceuticals selloff a buying opportunity, says Piper Sandler
03/05/21 Alliance Global Partners
Syros price target lowered to $14 from $18 at Alliance Global Partners
VOR Vor Biopharma
$13.15 /

+0.5 (+3.95%)

12/03/21 Baird
Baird start Vor Biopharma with an Outperform ahead of AML data
12/02/21 Baird
Vor Biopharma initiated with an Outperform at Baird
12/01/21 Oppenheimer
Vor Biopharma initiated with an Outperform at Oppenheimer
10/19/21 JMP Securities
Vor Biopharma initiated with an Outperform at JMP Securities
VOR Vor Biopharma
$13.15 /

+0.5 (+3.95%)

SYRS Syros Pharmaceuticals
$3.96 /

+0.39 (+10.92%)

SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

PRTA Prothena
$44.06 /

-2.565 (-5.50%)

NXTC NextCure
$5.84 /

+0.1 (+1.74%)

MOR MorphoSys
$9.07 /

-0.39 (-4.12%)

KURA Kura Oncology
$12.41 /

-0.05 (-0.40%)

IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

INBX Inhibrx
$36.50 /

-0.49 (-1.32%)

HOOK Hookipa Pharma
$2.94 /

+ (+0.00%)

GMDA Gamida Cell
$2.34 /

-0.015 (-0.64%)

EFTR eFfector Therapeutics
$7.44 /

+1.7 (+29.62%)

DCPH Deciphera
$8.03 /

+0.03 (+0.38%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

CUE Cue Biopharma
$10.94 /

-0.45 (-3.95%)

CTIC CTI BioPharma
$1.68 /

+0.075 (+4.69%)

CLLS Cellectis
$8.08 /

-0.18 (-2.18%)

CGEN Compugen
$4.20 /

+0.03 (+0.72%)

BPMC Blueprint Medicines
$95.36 /

+1.105 (+1.17%)

BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

BCAB BioAtla
$22.46 /

+0.105 (+0.47%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

  • 13
    Oct
  • 11
    Aug
  • 16
    Jun
  • 01
    Apr
  • 24
    Mar
  • 05
    Feb
  • 28
    Jan
  • 20
    Jan
  • 16
    Dec
  • 16
    Dec
  • 11
    Dec
  • 09
    Dec
  • 09
    Dec
SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

CGEN Compugen
$4.20 /

+0.03 (+0.72%)

SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

PRTA Prothena
$44.06 /

-2.565 (-5.50%)

MOR MorphoSys
$9.07 /

-0.39 (-4.12%)

KURA Kura Oncology
$12.41 /

-0.05 (-0.40%)

IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

DCPH Deciphera
$8.03 /

+0.03 (+0.38%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

CTIC CTI BioPharma
$1.68 /

+0.075 (+4.69%)

CGEN Compugen
$4.20 /

+0.03 (+0.72%)

BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

INBX Inhibrx
$36.50 /

-0.49 (-1.32%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

BCAB BioAtla
$22.46 /

+0.105 (+0.47%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

Conference/Events
JMP Securities to hold a virtual summit » 10:28
12/06/21
12/06
10:28
12/06/21
10:28
ALLO

Allogene Therapeutics

$17.54 /

-0.1 (-0.57%)

, BCYC

Bicycle Therapeutics

$51.39 /

-1.2 (-2.28%)

, BCAB

BioAtla

$23.00 /

+0.65 (+2.91%)

, BCRX

BioCryst

$10.98 /

-0.47 (-4.10%)

, BPMC

Blueprint Medicines

$93.08 /

-1.175 (-1.25%)

, CLLS

Cellectis

$8.11 /

-0.15 (-1.82%)

, CGEN

Compugen

$4.17 /

+ (+0.00%)

, CTIC

CTI BioPharma

$1.55 /

-0.05 (-3.13%)

, CUE

Cue Biopharma

$11.08 /

-0.31 (-2.72%)

, CVAC

CureVac

$42.70 /

-0.97 (-2.22%)

, DCPH

Deciphera

$8.00 /

+ (+0.00%)

, EFTR

eFfector Therapeutics

$6.04 /

+0.3 (+5.23%)

, GMDA

Gamida Cell

$2.30 /

-0.055 (-2.34%)

, HOOK

Hookipa Pharma

$2.95 /

+0.01 (+0.34%)

, INBX

Inhibrx

$36.71 /

-0.28 (-0.76%)

, IOVA

Iovance Biotherapeutics

$16.75 /

+0.19 (+1.15%)

, KURA

Kura Oncology

$12.37 /

-0.09 (-0.72%)

, MGN

Mines Management

$1.13 /

+ (+0.00%)

, MOR

MorphoSys

$9.19 /

-0.27 (-2.85%)

, NXTC

NextCure

$5.79 /

+0.05 (+0.87%)

, PTGX

Protagonist Therapeutics

$32.52 /

+0.18 (+0.56%)

, PRTA

Prothena

$45.07 /

-1.555 (-3.34%)

, SPPI

Spectrum

$1.37 /

-0.01 (-0.73%)

, SYRS

Syros Pharmaceuticals

$3.60 /

+0.03 (+0.84%)

, VOR

Vor Biopharma

$12.80 /

+0.15 (+1.19%)

Hematology & Oncology…

Hematology & Oncology Virtual Summit to be held on December 6-7.Webcast Link

ShowHide Related Items >><<
VOR Vor Biopharma
$12.80 /

+0.15 (+1.19%)

SYRS Syros Pharmaceuticals
$3.60 /

+0.03 (+0.84%)

SPPI Spectrum
$1.37 /

-0.01 (-0.73%)

PTGX Protagonist Therapeutics
$32.52 /

+0.18 (+0.56%)

PRTA Prothena
$45.07 /

-1.555 (-3.34%)

NXTC NextCure
$5.79 /

+0.05 (+0.87%)

MOR MorphoSys
$9.19 /

-0.27 (-2.85%)

KURA Kura Oncology
$12.37 /

-0.09 (-0.72%)

IOVA Iovance Biotherapeutics
$16.75 /

+0.19 (+1.15%)

INBX Inhibrx
$36.71 /

-0.28 (-0.76%)

HOOK Hookipa Pharma
$2.95 /

+0.01 (+0.34%)

GMDA Gamida Cell
$2.30 /

-0.055 (-2.34%)

EFTR eFfector Therapeutics
$6.04 /

+0.3 (+5.23%)

DCPH Deciphera
$8.00 /

+ (+0.00%)

CVAC CureVac
$42.70 /

-0.97 (-2.22%)

CUE Cue Biopharma
$11.08 /

-0.31 (-2.72%)

CTIC CTI BioPharma
$1.55 /

-0.05 (-3.13%)

CLLS Cellectis
$8.11 /

-0.15 (-1.82%)

CGEN Compugen
$4.17 /

+ (+0.00%)

BPMC Blueprint Medicines
$93.08 /

-1.175 (-1.25%)

BCYC Bicycle Therapeutics
$51.39 /

-1.2 (-2.28%)

BCRX BioCryst
$10.98 /

-0.47 (-4.10%)

ALLO Allogene Therapeutics
$17.54 /

-0.1 (-0.57%)

ALLO Allogene Therapeutics
$17.54 /

-0.1 (-0.57%)

12/03/21 Canaccord
Allogene Therapeutics clinical hold could be lifted shortly, says Canaccord
10/19/21 Cowen
Allogene Therapeutics assumed with an Outperform at Cowen
10/12/21 JMP Securities
Allogene Therapeutics price target lowered to $27 from $53 at JMP Securities
10/08/21
Fly Intel: Top five analyst downgrades
BCYC Bicycle Therapeutics
$51.39 /

-1.2 (-2.28%)

10/14/21 JMP Securities
Bicycle Therapeutics price target raised to $85 from $53 at JMP Securities
10/11/21 Canaccord
Bicycle Therapeutics price target raised to $60 from $40 at Canaccord
10/08/21 Oppenheimer
Bicycle Therapeutics price target raised to $65 from $47 at Oppenheimer
10/08/21 B. Riley
Bicycle Therapeutics price target raised to $72 from $56 at B. Riley
BCAB BioAtla
$23.00 /

+0.65 (+2.91%)

10/14/21 BTIG
BioAtla assumed with a Buy at BTIG
06/28/21 Roth Capital
BioAtla initiated with a Buy at Roth Capital
05/04/21 Credit Suisse
BioAtla assumed with an Outperform at Credit Suisse
05/04/21 JPMorgan
BioAtla price target raised to $64 from $45 at JPMorgan
BCRX BioCryst
$10.98 /

-0.47 (-4.10%)

11/22/21 Piper Sandler
BioCryst financing lifts one of two overhangs, says Piper Sandler
11/04/21 Barclays
BioCryst price target lowered to $17 from $21 at Barclays
11/03/21 Piper Sandler
BioCryst earnings pullback a buying opportunity, says Piper Sandler
08/06/21 Jefferies
BioCryst downgraded to Hold from Buy at Jefferies
BPMC Blueprint Medicines
$93.08 /

-1.175 (-1.25%)

12/01/21 Raymond James
Blueprint Medicines added to Analyst Current Favorites list at Raymond James
11/29/21 Stifel
Stifel expects neutral reaction for Blueprint acquisition of Lengo Therapeutics
11/29/21 Piper Sandler
Blueprint acquisition may surprise investors looking for buyout, says Piper
11/19/21 Morgan Stanley
Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
CLLS Cellectis
$8.11 /

-0.15 (-1.82%)

11/30/21 JMP Securities
Cellectis initiated with an Outperform at JMP Securities
11/08/21 William Blair
Cellectis downgraded to Market Perform at William Blair on slow execution
11/08/21 William Blair
Cellectis downgraded to Market Perform from Outperform at William Blair
10/08/21 Baird
Baird cuts Cellectis to Neutral after partner Allogene's clinical hold
CGEN Compugen
$4.17 /

+ (+0.00%)

CTIC CTI BioPharma
$1.55 /

-0.05 (-3.13%)

12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
CUE Cue Biopharma
$11.08 /

-0.31 (-2.72%)

CVAC CureVac
$42.70 /

-0.97 (-2.22%)

10/22/21
Fly Intel: Top five analyst initiations
10/22/21 Deutsche Bank
CureVac initiated with a Hold at Deutsche Bank
07/01/21 Berenberg
CureVac COVID vaccine data may be enough for EU approval, says Berenberg
06/30/21
CureVac announces COVID vaccine candidate demonstrates 48% efficacy
DCPH Deciphera
$8.00 /

+ (+0.00%)

12/01/21 H.C. Wainwright
Deciphera price target lowered to $15 from $25 at H.C. Wainwright
11/30/21 Piper Sandler
Deciphera price target lowered to $11 from $14 at Piper Sandler
11/08/21 Barclays
Deciphera downgraded to Equal Weight at Barclays after GIST trial miss
11/08/21 Canaccord
Deciphera downgraded to Hold at Canaccord
EFTR eFfector Therapeutics
$6.04 /

+0.3 (+5.23%)

11/08/21 Stifel
eFfector Therapeutics upgraded to Buy at Stifel on NSCLC optimism
11/08/21 Stifel
eFfector Therapeutics upgraded to Buy from Hold at Stifel
10/12/21 Credit Suisse
eFfector Therapeutics initiated with an Outperform at Credit Suisse
10/04/21 Mizuho
eFfector Therapeutics initiated with a Buy at Mizuho
GMDA Gamida Cell
$2.30 /

-0.055 (-2.34%)

11/16/21 H.C. Wainwright
Gamida Cell price target lowered to $22 from $27 at H.C. Wainwright
11/16/21 Oppenheimer
Gamida Cell price target lowered to $15 from $17 at Oppenheimer
11/15/21 Piper Sandler
Gamida Cell price target lowered to $13 from $23 at Piper Sandler
11/01/21 Alliance Global Partners
Gamida Cell initiated with a Buy at Alliance Global Partners
HOOK Hookipa Pharma
$2.95 /

+0.01 (+0.34%)

11/12/21 Morgan Stanley
Morgan Stanley downgrades Hookipa to Equal Weight after oncology data update
11/12/21 Morgan Stanley
Hookipa Pharma downgraded to Equal Weight from Overweight at Morgan Stanley
11/11/21 H.C. Wainwright
Hookipa Pharma price target lowered to $15 from $21 at H.C. Wainwright
11/10/21 JMP Securities
Hookipa Pharma price target lowered to $11 from $25 at JMP Securities
INBX Inhibrx
$36.71 /

-0.28 (-0.76%)

11/10/21 Credit Suisse
Inhibrx price target raised to $53 from $44 at Credit Suisse
11/02/21 JMP Securities
Inhibrx price target raised to $53 from $46 at JMP Securities
09/21/21 JMP Securities
Inhibrx initiated with an Outperform at JMP Securities
04/26/21 Credit Suisse
Inhibrx assumed with an Outperform at Credit Suisse
IOVA Iovance Biotherapeutics
$16.75 /

+0.19 (+1.15%)

11/15/21 Oppenheimer
Iovance price target lowered to $31 from $38 at Oppenheimer
11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
KURA Kura Oncology
$12.37 /

-0.09 (-0.72%)

11/26/21 Credit Suisse
Kura Oncology price target lowered to $21 from $40 at Credit Suisse
11/24/21 H.C. Wainwright
Kura Oncology price target lowered to $32 from $43 at H.C. Wainwright
05/04/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
04/26/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
MGN Mines Management
$1.13 /

+ (+0.00%)

MOR MorphoSys
$9.19 /

-0.27 (-2.85%)

11/12/21 Morgan Stanley
MorphoSys price target raised to EUR 76 from EUR 75 at Morgan Stanley
09/27/21 Citi
MorphoSys downgraded to Neutral from Buy at Citi
09/13/21 Goldman Sachs
MorphoSys reinstated with a Neutral at Goldman Sachs
09/02/21 Barclays
MorphoSys price target lowered to EUR 47 from EUR 90 at Barclays
NXTC NextCure
$5.79 /

+0.05 (+0.87%)

11/05/21 Piper Sandler
NextCure's Phase II NC318 study continuing weekly dosing, says Piper Sandler
08/08/21 Piper Sandler
NextCure price target lowered to $21 from $26 at Piper Sandler
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
PTGX Protagonist Therapeutics
$32.52 /

+0.18 (+0.56%)

11/15/21 JMP Securities
Protagonist Therapeutics price target raised to $70 from $60 at JMP Securities
11/04/21 Piper Sandler
Piper 'pleasantly surprised' by Protagonist Therapeutics' ASH abstracts
10/13/21 JMP Securities
Protagonist Therapeutics price target raised to $60 from $47 at JMP Securities
10/12/21 JPMorgan
JPMorgan upgrades Protagonist after 'rapid' clinical hold removal
PRTA Prothena
$45.07 /

-1.555 (-3.34%)

11/19/21 JMP Securities
Prothena initiated with an Outperform at JMP Securities
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
09/27/21 Oppenheimer
Prothena price target raised to $100 from $90 at Oppenheimer
09/20/21 Fox Advisors
Prothena initiated with an Overweight at Fox Advisors
SPPI Spectrum
$1.37 /

-0.01 (-0.73%)

08/18/21 B. Riley
Spectrum price target lowered to $6 from $8 at B. Riley
06/01/21 H.C. Wainwright
H.C. Wainwright remains bullish on Spectrum as FDA inspects Rolontis facility
SYRS Syros Pharmaceuticals
$3.60 /

+0.03 (+0.84%)

09/27/21 Roth Capital
Veteran Chee coming aboard a positive for Syros, says Roth Capital
09/23/21 Roth Capital
Syros Pharmaceuticals price target raised to $23 from $20 at Roth Capital
05/06/21 Piper Sandler
Syros Pharmaceuticals selloff a buying opportunity, says Piper Sandler
03/05/21 Alliance Global Partners
Syros price target lowered to $14 from $18 at Alliance Global Partners
VOR Vor Biopharma
$12.80 /

+0.15 (+1.19%)

12/03/21 Baird
Baird start Vor Biopharma with an Outperform ahead of AML data
12/02/21 Baird
Vor Biopharma initiated with an Outperform at Baird
12/01/21 Oppenheimer
Vor Biopharma initiated with an Outperform at Oppenheimer
10/19/21 JMP Securities
Vor Biopharma initiated with an Outperform at JMP Securities
VOR Vor Biopharma
$12.80 /

+0.15 (+1.19%)

SYRS Syros Pharmaceuticals
$3.60 /

+0.03 (+0.84%)

SPPI Spectrum
$1.37 /

-0.01 (-0.73%)

PTGX Protagonist Therapeutics
$32.52 /

+0.18 (+0.56%)

PRTA Prothena
$45.07 /

-1.555 (-3.34%)

NXTC NextCure
$5.79 /

+0.05 (+0.87%)

MOR MorphoSys
$9.19 /

-0.27 (-2.85%)

KURA Kura Oncology
$12.37 /

-0.09 (-0.72%)

IOVA Iovance Biotherapeutics
$16.75 /

+0.19 (+1.15%)

INBX Inhibrx
$36.71 /

-0.28 (-0.76%)

HOOK Hookipa Pharma
$2.95 /

+0.01 (+0.34%)

GMDA Gamida Cell
$2.30 /

-0.055 (-2.34%)

EFTR eFfector Therapeutics
$6.04 /

+0.3 (+5.23%)

DCPH Deciphera
$8.00 /

+ (+0.00%)

CVAC CureVac
$42.70 /

-0.97 (-2.22%)

CUE Cue Biopharma
$11.08 /

-0.31 (-2.72%)

CTIC CTI BioPharma
$1.55 /

-0.05 (-3.13%)

CLLS Cellectis
$8.11 /

-0.15 (-1.82%)

CGEN Compugen
$4.17 /

+ (+0.00%)

BPMC Blueprint Medicines
$93.08 /

-1.175 (-1.25%)

BCYC Bicycle Therapeutics
$51.39 /

-1.2 (-2.28%)

BCRX BioCryst
$10.98 /

-0.47 (-4.10%)

BCAB BioAtla
$23.00 /

+0.65 (+2.91%)

ALLO Allogene Therapeutics
$17.54 /

-0.1 (-0.57%)

  • 13
    Oct
  • 11
    Aug
  • 16
    Jun
  • 01
    Apr
  • 24
    Mar
  • 05
    Feb
  • 28
    Jan
  • 20
    Jan
  • 16
    Dec
  • 16
    Dec
  • 11
    Dec
  • 09
    Dec
  • 09
    Dec
SPPI Spectrum
$1.37 /

-0.01 (-0.73%)

CVAC CureVac
$42.70 /

-0.97 (-2.22%)

CGEN Compugen
$4.17 /

+ (+0.00%)

SPPI Spectrum
$1.37 /

-0.01 (-0.73%)

PTGX Protagonist Therapeutics
$32.52 /

+0.18 (+0.56%)

PRTA Prothena
$45.07 /

-1.555 (-3.34%)

MOR MorphoSys
$9.19 /

-0.27 (-2.85%)

KURA Kura Oncology
$12.37 /

-0.09 (-0.72%)

IOVA Iovance Biotherapeutics
$16.75 /

+0.19 (+1.15%)

DCPH Deciphera
$8.00 /

+ (+0.00%)

CVAC CureVac
$42.70 /

-0.97 (-2.22%)

CTIC CTI BioPharma
$1.55 /

-0.05 (-3.13%)

CGEN Compugen
$4.17 /

+ (+0.00%)

BCYC Bicycle Therapeutics
$51.39 /

-1.2 (-2.28%)

BCRX BioCryst
$10.98 /

-0.47 (-4.10%)

ALLO Allogene Therapeutics
$17.54 /

-0.1 (-0.57%)

SPPI Spectrum
$1.37 /

-0.01 (-0.73%)

PTGX Protagonist Therapeutics
$32.52 /

+0.18 (+0.56%)

IOVA Iovance Biotherapeutics
$16.75 /

+0.19 (+1.15%)

INBX Inhibrx
$36.71 /

-0.28 (-0.76%)

CVAC CureVac
$42.70 /

-0.97 (-2.22%)

BCYC Bicycle Therapeutics
$51.39 /

-1.2 (-2.28%)

BCRX BioCryst
$10.98 /

-0.47 (-4.10%)

BCAB BioAtla
$23.00 /

+0.65 (+2.91%)

ALLO Allogene Therapeutics
$17.54 /

-0.1 (-0.57%)

On The Fly
Wall Street in Fives - Must Read Lists for Wednesday » 16:28
12/01/21
12/01
16:28
12/01/21
16:28
CRM

Salesforce

$251.50 /

-33.51 (-11.76%)

, XOM

Exxon Mobil

$59.78 /

-0.02 (-0.03%)

, HPE

HP Enterprise

$14.20 /

-0.18 (-1.25%)

, MRK

Merck

$74.43 /

-0.43 (-0.57%)

, SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$450.52 /

-5.32 (-1.17%)

, DNUT

Krispy Kreme

$13.18 /

-1.33 (-9.17%)

, DASH

DoorDash

$161.43 /

-17.335 (-9.70%)

, COF

Capital One

$138.35 /

-2.145 (-1.53%)

, DHI

D.R. Horton

$97.76 /

+0.02 (+0.02%)

, LEN

Lennar

$108.58 /

+3.52 (+3.35%)

, SKX

Skechers

$44.56 /

-0.36 (-0.80%)

, MRNA

Moderna

$310.58 /

-42.12 (-11.94%)

, AZN

AstraZeneca

$54.88 /

+0.05 (+0.09%)

, ABUS

Arbutus Biopharma

$4.60 /

+1.4 (+43.75%)

, JNJ

Johnson & Johnson

$158.16 /

+2.2 (+1.41%)

, AMGN

Amgen

$200.66 /

+1.78 (+0.90%)

, BBW

Build-A-Bear

$21.56 /

+4.67 (+27.65%)

, GIII

G-III Apparel

$30.47 /

+0.73 (+2.45%)

, BYSI

BeyondSpring

$4.94 /

-7.825 (-61.32%)

, CTIC

CTI BioPharma

$1.62 /

-0.615 (-27.52%)

, BIRD

Allbirds

$16.04 /

-3.235 (-16.78%)

, BOX

Box

$25.84 /

+2.37 (+10.10%)

, GFS

GlobalFoundries

$66.10 /

-3.32 (-4.78%)

, AMBA

Ambarella

$204.60 /

+24.69 (+13.72%)

, ZS

Zscaler

$318.19 /

-29.02 (-8.36%)

, GCP

GCP Applied Technologies

$26.65 /

+3.295 (+14.11%)

, BALY

Bally's

$35.65 /

-2.7 (-7.04%)

, WYNN

Wynn Resorts

$76.11 /

-5.01 (-6.18%)

, CZR

Caesars

$83.16 /

-6.855 (-7.62%)

Get caught up quickly on…

ShowHide Related Items >><<
ZS Zscaler
$318.19 /

-29.02 (-8.36%)

XOM Exxon Mobil
$59.78 /

-0.02 (-0.03%)

WYNN Wynn Resorts
$76.11 /

-5.01 (-6.18%)

SPY SPDR S&P 500 ETF Trust
$450.52 /

-5.32 (-1.17%)

SPX S&P 500
/

+

SKX Skechers
$44.56 /

-0.36 (-0.80%)

MRNA Moderna
$310.58 /

-42.12 (-11.94%)

MRK Merck
$74.43 /

-0.43 (-0.57%)

LEN Lennar
$108.58 /

+3.52 (+3.35%)

JNJ Johnson & Johnson
$158.16 /

+2.2 (+1.41%)

HPE HP Enterprise
$14.20 /

-0.18 (-1.25%)

GIII G-III Apparel
$30.47 /

+0.73 (+2.45%)

GFS GlobalFoundries
$66.10 /

-3.32 (-4.78%)

GCP GCP Applied Technologies
$26.65 /

+3.295 (+14.11%)

DNUT Krispy Kreme
$13.18 /

-1.33 (-9.17%)

DHI D.R. Horton
$97.76 /

+0.02 (+0.02%)

DASH DoorDash
$161.43 /

-17.335 (-9.70%)

CZR Caesars
$83.16 /

-6.855 (-7.62%)

CTIC CTI BioPharma
$1.62 /

-0.615 (-27.52%)

CRM Salesforce
$251.50 /

-33.51 (-11.76%)

COF Capital One
$138.35 /

-2.145 (-1.53%)

BYSI BeyondSpring
$4.94 /

-7.825 (-61.32%)

BOX Box
$25.84 /

+2.37 (+10.10%)

BBW Build-A-Bear
$21.56 /

+4.67 (+27.65%)

BALY Bally's
$35.65 /

-2.7 (-7.04%)

AZN AstraZeneca
$54.88 /

+0.05 (+0.09%)

AMGN Amgen
$200.66 /

+1.78 (+0.90%)

AMBA Ambarella
$204.60 /

+24.69 (+13.72%)

ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

CRM Salesforce
$251.50 /

-33.51 (-11.76%)

12/01/21 Jefferies
Salesforce promotion of Taylor to co-CEO a positive, says Jefferies
12/01/21 Morgan Stanley
Salesforce Q3 'likely fell short' of expectations, says Morgan Stanley
12/01/21 Truist
Salesforce price target raised to $330 from $315 at Truist
12/01/21 UBS
Salesforce price target lowered to $315 from $330 at UBS
XOM Exxon Mobil
$59.78 /

-0.02 (-0.03%)

11/02/21
Fly Intel: Top five analyst downgrades
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
10/21/21 Morgan Stanley
Exxon Mobil, Chevron look poised for 'catch up trade,' says Morgan Stanley
HPE HP Enterprise
$14.20 /

-0.18 (-1.25%)

12/01/21 Raymond James
HP Enterprise price target raised to $21 from $20 at Raymond James
12/01/21 Citi
Citi cuts HP Enterprise target, opens pair trade with NetApp
11/11/21 Goldman Sachs
HP Enterprise downgraded to Sell from Neutral at Goldman Sachs
10/06/21 Morgan Stanley
HP Enterprise price target lowered to $16 from $18 at Morgan Stanley
MRK Merck
$74.43 /

-0.43 (-0.57%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
SPX S&P 500
/

+

11/26/21 Morgan Stanley
Covid variant mutations may reduce vaccine effectiveness, says Morgan Stanley
11/26/21 Credit Suisse
Concerns over new Covid variant 'understandable,' says Credit Suisse
11/22/21 BTIG
In picking Powell, Biden went with 'safest choice,' says BTIG
08/04/21 Citi
Citi sees 10-year yield rising to 2%, cuts 'tech-heavy' U.S. to Neutral
SPY SPDR S&P 500 ETF Trust
$450.52 /

-5.32 (-1.17%)

DNUT Krispy Kreme
$13.18 /

-1.33 (-9.17%)

12/01/21
Fly Intel: Top five analyst downgrades
12/01/21 Goldman Sachs
Krispy Kreme downgraded to Sell from Neutral at Goldman Sachs
11/08/21
Fly Intel: Top five analyst downgrades
11/08/21 Truist
Krispy Kreme downgraded to Hold from Buy at Truist
DASH DoorDash
$161.43 /

-17.335 (-9.70%)

12/02/21 UBS
DoorDash initiated with a Neutral at UBS
12/01/21
Fly Intel: Top five analyst upgrades
12/01/21 Gordon Haskett
Gordon Haskett sees 'compelling re-entry point,' upgrades DoorDash to Buy
12/01/21 Gordon Haskett
DoorDash upgraded to Buy from Hold at Gordon Haskett
COF Capital One
$138.35 /

-2.145 (-1.53%)

12/01/21 Baird
Capital One upgraded to Neutral after underperformance at Baird
12/01/21 Baird
Capital One upgraded to Neutral from Underperform at Baird
10/27/21 Credit Suisse
Capital One price target raised to $190 from $184 at Credit Suisse
DHI D.R. Horton
$97.76 /

+0.02 (+0.02%)

12/01/21 Goldman Sachs
D.R. Horton downgraded to Neutral from Buy at Goldman Sachs
11/17/21 Raymond James
D.R. Horton price target raised to $120 from $110 at Raymond James
11/11/21 Citi
D.R. Horton price target raised to $116 from $104 at Citi
LEN Lennar
$108.58 /

+3.52 (+3.35%)

12/01/21 Goldman Sachs
Lennar upgraded to Buy from Neutral at Goldman Sachs
11/08/21 BofA
Lennar reinstated with a Buy at BofA
10/14/21 JPMorgan
Lennar price target lowered to $127 from $143 at JPMorgan
SKX Skechers
$44.56 /

-0.36 (-0.80%)

11/02/21 Argus
Skechers downgraded to Hold from Buy at Argus
10/29/21 B. Riley
Skechers growth thesis intact despite Q3 miss, says B. Riley
10/19/21
Fly Intel: Top five analyst upgrades
MRNA Moderna
$310.58 /

-42.12 (-11.94%)

11/28/21 Piper Sandler
Moderna has multiple booster candidates to combat omicron, says Piper Sandler
11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
AZN AstraZeneca
$54.88 /

+0.05 (+0.09%)

11/29/21 Morgan Stanley
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Morgan Stanley
11/22/21 Bryan Garnier
AstraZeneca downgraded to Buy from Conviction Buy at Bryan Garnier
10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

12/02/21 Chardan
Arbutus Biopharma price target raised to $5.50 from $5 at Chardan
11/08/21 H.C. Wainwright
Arbutus Biopharma price target lowered to $8 from $10 at H.C. Wainwright
06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
JNJ Johnson & Johnson
$158.16 /

+2.2 (+1.41%)

11/29/21 Credit Suisse
Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
11/08/21 Morgan Stanley
Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
AMGN Amgen
$200.66 /

+1.78 (+0.90%)

11/22/21 Mizuho
Amgen price target lowered to $194 from $222 at Mizuho
11/18/21 BMO Capital
Amgen initiated with a Market Perform at BMO Capital
11/01/21 Oppenheimer
Amgen price target lowered to $272 from $277 at Oppenheimer
10/04/21 Piper Sandler
Amgen's AMG 451 looks competitive with Dupixent, says Piper Sandler
BBW Build-A-Bear
$21.56 /

+4.67 (+27.65%)

GIII G-III Apparel
$30.47 /

+0.73 (+2.45%)

06/08/21 B. Riley
G-III Apparel price target raised to $41 from $39 at B. Riley
06/08/21 Barclays
G-III Apparel price target raised to $30 from $27 at Barclays
03/19/21 B. Riley
G-III Apparel price target raised to $38 from $33 at B. Riley Securities
03/19/21 Barclays
G-III Apparel price target raised to $27 from $24 at Barclays
BYSI BeyondSpring
$4.94 /

-7.825 (-61.32%)

12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
12/01/21 William Blair
BeyondSpring cut to Market Perform at William Blair after CRL for plinabulin
CTIC CTI BioPharma
$1.62 /

-0.615 (-27.52%)

12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
BIRD Allbirds
$16.04 /

-3.235 (-16.78%)

12/01/21 Morgan Stanley
Morgan Stanley says Allbirds investors may have been seeking upside
11/29/21
Fly Intel: Top five analyst initiations
11/29/21 Guggenheim
Guggenheim starts Allbirds at Buy, sees 50% potential upside
11/29/21 Guggenheim
Allbirds initiated with a Buy at Guggenheim
BOX Box
$25.84 /

+2.37 (+10.10%)

12/02/21 Berenberg
Box price target raised to $34 from $30 at Berenberg
12/01/21 Craig-Hallum
Box price target raised to $38 from $31 at Craig-Hallum
12/01/21 Morgan Stanley
Box price target raised to $30 at Morgan Stanley after 'beat and raise quarter'
12/01/21 Raymond James
Box price target raised to $30 from $29 at Raymond James
GFS GlobalFoundries
$66.10 /

-3.32 (-4.78%)

12/01/21 Morgan Stanley
GlobalFoundries target up to $68 at Morgan Stanley after 'solid' first report
12/01/21 Credit Suisse
GlobalFoundries price target raised to $80 from $75 at Credit Suisse
12/01/21 Deutsche Bank
GlobalFoundries price target raised to $78 from $75 at Deutsche Bank
11/22/21
Fly Intel: Top five analyst initiations
AMBA Ambarella
$204.60 /

+24.69 (+13.72%)

12/01/21 Colliers
Ambarella price target raised to $245 from $135 at Colliers
12/01/21 Cowen
Ambarella price target raised to $235 from $150
12/01/21 Craig-Hallum
Ambarella price target raised to $250 from $170 at Craig-Hallum
12/01/21 Morgan Stanley
Ambarella price target raised to $229 from $222 at Morgan Stanley
ZS Zscaler
$318.19 /

-29.02 (-8.36%)

12/01/21 Truist
Zscaler price target raised to $400 from $325 at Truist
12/01/21 Wedbush
Zscaler price target raised to $400 from $320 at Wedbush
12/01/21 Canaccord
Zscaler price target raised to $400 from $340 at Canaccord
12/01/21 Needham
Zscaler price target raised to $418 from $390 at Needham
GCP GCP Applied Technologies
$26.65 /

+3.295 (+14.11%)

BALY Bally's
$35.65 /

-2.7 (-7.04%)

11/09/21 KeyBanc
Bally's price target lowered to $65 from $70 at KeyBanc
10/27/21
Fly Intel: Top five analyst initiations
10/27/21 Goldman Sachs
Bally's initiated with a Neutral at Goldman Sachs
10/26/21
Fly Intel: Top five analyst upgrades
WYNN Wynn Resorts
$76.11 /

-5.01 (-6.18%)

11/10/21 Wells Fargo
Wynn Resorts price target lowered to $101 from $112 at Wells Fargo
11/10/21 Deutsche Bank
Wynn Resorts price target lowered to $131 from $140 at Deutsche Bank
11/10/21 Stifel
Wynn Resorts price target raised to $124 from $107 at Stifel
10/20/21 Morgan Stanley
Wynn Resorts price target lowered to $107 from $113 at Morgan Stanley
CZR Caesars
$83.16 /

-6.855 (-7.62%)

11/29/21 Deutsche Bank
Caesars price target lowered to $130 from $132 at Deutsche Bank
11/12/21
Fly Intel: Top five analyst initiations
11/12/21 B. Riley
B. Riley starts 'mispriced empire' Caesars with Buy, $191 target
11/12/21 B. Riley
Caesars initiated with a Buy at B. Riley
ZS Zscaler
$318.19 /

-29.02 (-8.36%)

XOM Exxon Mobil
$59.78 /

-0.02 (-0.03%)

WYNN Wynn Resorts
$76.11 /

-5.01 (-6.18%)

SKX Skechers
$44.56 /

-0.36 (-0.80%)

MRNA Moderna
$310.58 /

-42.12 (-11.94%)

MRK Merck
$74.43 /

-0.43 (-0.57%)

LEN Lennar
$108.58 /

+3.52 (+3.35%)

JNJ Johnson & Johnson
$158.16 /

+2.2 (+1.41%)

HPE HP Enterprise
$14.20 /

-0.18 (-1.25%)

GIII G-III Apparel
$30.47 /

+0.73 (+2.45%)

GFS GlobalFoundries
$66.10 /

-3.32 (-4.78%)

GCP GCP Applied Technologies
$26.65 /

+3.295 (+14.11%)

DNUT Krispy Kreme
$13.18 /

-1.33 (-9.17%)

DHI D.R. Horton
$97.76 /

+0.02 (+0.02%)

DASH DoorDash
$161.43 /

-17.335 (-9.70%)

CZR Caesars
$83.16 /

-6.855 (-7.62%)

CTIC CTI BioPharma
$1.62 /

-0.615 (-27.52%)

CRM Salesforce
$251.50 /

-33.51 (-11.76%)

COF Capital One
$138.35 /

-2.145 (-1.53%)

BYSI BeyondSpring
$4.94 /

-7.825 (-61.32%)

BOX Box
$25.84 /

+2.37 (+10.10%)

BIRD Allbirds
$16.04 /

-3.235 (-16.78%)

BBW Build-A-Bear
$21.56 /

+4.67 (+27.65%)

BALY Bally's
$35.65 /

-2.7 (-7.04%)

AZN AstraZeneca
$54.88 /

+0.05 (+0.09%)

AMGN Amgen
$200.66 /

+1.78 (+0.90%)

AMBA Ambarella
$204.60 /

+24.69 (+13.72%)

ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

  • 03
    Nov
  • 28
    Oct
  • 19
    Aug
  • 01
    Jul
  • 20
    May
  • 16
    Apr
  • 01
    Apr
  • 09
    Feb
  • 09
    Dec
ZS Zscaler
$318.19 /

-29.02 (-8.36%)

XOM Exxon Mobil
$59.78 /

-0.02 (-0.03%)

WYNN Wynn Resorts
$76.11 /

-5.01 (-6.18%)

SPX S&P 500
/

+

SKX Skechers
$44.56 /

-0.36 (-0.80%)

MRNA Moderna
$310.58 /

-42.12 (-11.94%)

MRK Merck
$74.43 /

-0.43 (-0.57%)

LEN Lennar
$108.58 /

+3.52 (+3.35%)

JNJ Johnson & Johnson
$158.16 /

+2.2 (+1.41%)

HPE HP Enterprise
$14.20 /

-0.18 (-1.25%)

GCP GCP Applied Technologies
$26.65 /

+3.295 (+14.11%)

DNUT Krispy Kreme
$13.18 /

-1.33 (-9.17%)

DHI D.R. Horton
$97.76 /

+0.02 (+0.02%)

DASH DoorDash
$161.43 /

-17.335 (-9.70%)

CRM Salesforce
$251.50 /

-33.51 (-11.76%)

COF Capital One
$138.35 /

-2.145 (-1.53%)

BOX Box
$25.84 /

+2.37 (+10.10%)

BALY Bally's
$35.65 /

-2.7 (-7.04%)

AZN AstraZeneca
$54.88 /

+0.05 (+0.09%)

ZS Zscaler
$318.19 /

-29.02 (-8.36%)

XOM Exxon Mobil
$59.78 /

-0.02 (-0.03%)

SPX S&P 500
/

+

SKX Skechers
$44.56 /

-0.36 (-0.80%)

MRNA Moderna
$310.58 /

-42.12 (-11.94%)

MRK Merck
$74.43 /

-0.43 (-0.57%)

LEN Lennar
$108.58 /

+3.52 (+3.35%)

JNJ Johnson & Johnson
$158.16 /

+2.2 (+1.41%)

HPE HP Enterprise
$14.20 /

-0.18 (-1.25%)

GIII G-III Apparel
$30.47 /

+0.73 (+2.45%)

GFS GlobalFoundries
$66.10 /

-3.32 (-4.78%)

DNUT Krispy Kreme
$13.18 /

-1.33 (-9.17%)

DHI D.R. Horton
$97.76 /

+0.02 (+0.02%)

DASH DoorDash
$161.43 /

-17.335 (-9.70%)

CRM Salesforce
$251.50 /

-33.51 (-11.76%)

COF Capital One
$138.35 /

-2.145 (-1.53%)

BYSI BeyondSpring
$4.94 /

-7.825 (-61.32%)

BOX Box
$25.84 /

+2.37 (+10.10%)

BALY Bally's
$35.65 /

-2.7 (-7.04%)

AZN AstraZeneca
$54.88 /

+0.05 (+0.09%)

AMGN Amgen
$200.66 /

+1.78 (+0.90%)

AMBA Ambarella
$204.60 /

+24.69 (+13.72%)

ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

ZS Zscaler
$318.19 /

-29.02 (-8.36%)

XOM Exxon Mobil
$59.78 /

-0.02 (-0.03%)

WYNN Wynn Resorts
$76.11 /

-5.01 (-6.18%)

SPY SPDR S&P 500 ETF Trust
$450.52 /

-5.32 (-1.17%)

SPX S&P 500
/

+

SKX Skechers
$44.56 /

-0.36 (-0.80%)

MRNA Moderna
$310.58 /

-42.12 (-11.94%)

MRK Merck
$74.43 /

-0.43 (-0.57%)

LEN Lennar
$108.58 /

+3.52 (+3.35%)

JNJ Johnson & Johnson
$158.16 /

+2.2 (+1.41%)

HPE HP Enterprise
$14.20 /

-0.18 (-1.25%)

GFS GlobalFoundries
$66.10 /

-3.32 (-4.78%)

DNUT Krispy Kreme
$13.18 /

-1.33 (-9.17%)

DHI D.R. Horton
$97.76 /

+0.02 (+0.02%)

DASH DoorDash
$161.43 /

-17.335 (-9.70%)

CZR Caesars
$83.16 /

-6.855 (-7.62%)

CRM Salesforce
$251.50 /

-33.51 (-11.76%)

COF Capital One
$138.35 /

-2.145 (-1.53%)

BYSI BeyondSpring
$4.94 /

-7.825 (-61.32%)

BOX Box
$25.84 /

+2.37 (+10.10%)

BIRD Allbirds
$16.04 /

-3.235 (-16.78%)

AZN AstraZeneca
$54.88 /

+0.05 (+0.09%)

AMGN Amgen
$200.66 /

+1.78 (+0.90%)

AMBA Ambarella
$204.60 /

+24.69 (+13.72%)

ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

SPY SPDR S&P 500 ETF Trust
$450.52 /

-5.32 (-1.17%)

SPX S&P 500
/

+

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:20
12/01/21
12/01
12:20
12/01/21
12:20
COF

Capital One

$142.66 /

+2.165 (+1.54%)

, LEN

Lennar

$109.64 /

+4.58 (+4.36%)

, ABUS

Arbutus Biopharma

$6.10 /

+2.9 (+90.63%)

, MRNA

Moderna

$321.88 /

-30.82 (-8.74%)

, CRM

Salesforce

$265.97 /

-19.04 (-6.68%)

, XOM

Exxon Mobil

$61.38 /

+1.58 (+2.64%)

, HPE

HP Enterprise

$14.49 /

+0.11 (+0.76%)

, MRK

Merck

$76.22 /

+1.36 (+1.82%)

, ZS

Zscaler

$327.43 /

-19.78 (-5.70%)

, UNCRY

UniCredit

$6.04 /

+0.072 (+1.21%)

, MCD

McDonald's

$249.99 /

+5.47 (+2.24%)

, MSFT

Microsoft

$338.11 /

+7.38 (+2.23%)

, STLA

Stellantis

$18.00 /

+0.855 (+4.99%)

, ME

23andMe

$8.15 /

-0.03 (-0.37%)

, IMGN

ImmunoGen

$7.10 /

+0.92 (+14.89%)

, BBW

Build-A-Bear

$22.03 /

+5.14 (+30.43%)

, GIII

G-III Apparel

$30.60 /

+0.86 (+2.89%)

, BYSI

BeyondSpring

$5.65 /

-7.11 (-55.72%)

, CTIC

CTI BioPharma

$1.81 /

-0.425 (-19.02%)

, BIRD

Allbirds

$16.44 /

-2.835 (-14.71%)

, BOX

Box

$26.30 /

+2.83 (+12.06%)

, GFS

GlobalFoundries

$67.74 /

-1.68 (-2.42%)

, AMBA

Ambarella

$221.50 /

+41.59 (+23.12%)

, CLS

Celestica

$10.14 /

-0.09 (-0.88%)

, DNUT

Krispy Kreme

$13.52 /

-0.99 (-6.82%)

, DASH

DoorDash

$175.32 /

-3.44 (-1.92%)

, DHI

D.R. Horton

$99.48 /

+1.74 (+1.78%)

Get caught up quickly on…

ShowHide Related Items >><<
ZS Zscaler
$327.43 /

-19.78 (-5.70%)

XOM Exxon Mobil
$61.38 /

+1.58 (+2.64%)

UNCRY UniCredit
$6.04 /

+0.072 (+1.21%)

STLA Stellantis
$18.00 /

+0.855 (+4.99%)

MSFT Microsoft
$338.11 /

+7.38 (+2.23%)

MRNA Moderna
$321.88 /

-30.82 (-8.74%)

MRK Merck
$76.22 /

+1.36 (+1.82%)

ME 23andMe
$8.15 /

-0.03 (-0.37%)

MCD McDonald's
$249.99 /

+5.47 (+2.24%)

LEN Lennar
$109.64 /

+4.58 (+4.36%)

IMGN ImmunoGen
$7.10 /

+0.92 (+14.89%)

HPE HP Enterprise
$14.49 /

+0.11 (+0.76%)

GIII G-III Apparel
$30.60 /

+0.86 (+2.89%)

GFS GlobalFoundries
$67.74 /

-1.68 (-2.42%)

DNUT Krispy Kreme
$13.52 /

-0.99 (-6.82%)

DHI D.R. Horton
$99.48 /

+1.74 (+1.78%)

DASH DoorDash
$175.32 /

-3.44 (-1.92%)

CTIC CTI BioPharma
$1.81 /

-0.425 (-19.02%)

CRM Salesforce
$265.97 /

-19.04 (-6.68%)

COF Capital One
$142.66 /

+2.165 (+1.54%)

CLS Celestica
$10.14 /

-0.09 (-0.88%)

BYSI BeyondSpring
$5.65 /

-7.11 (-55.72%)

BOX Box
$26.30 /

+2.83 (+12.06%)

BBW Build-A-Bear
$22.03 /

+5.14 (+30.43%)

AMBA Ambarella
$221.50 /

+41.59 (+23.12%)

ABUS Arbutus Biopharma
$6.10 /

+2.9 (+90.63%)

COF Capital One
$142.66 /

+2.165 (+1.54%)

12/01/21
Fly Intel: Top five analyst upgrades
12/01/21 Baird
Capital One upgraded to Neutral after underperformance at Baird
12/01/21 Baird
Capital One upgraded to Neutral from Underperform at Baird
10/27/21 Credit Suisse
Capital One price target raised to $190 from $184 at Credit Suisse
LEN Lennar
$109.64 /

+4.58 (+4.36%)

12/01/21 Goldman Sachs
Lennar upgraded to Buy from Neutral at Goldman Sachs
11/08/21 BofA
Lennar reinstated with a Buy at BofA
10/14/21 JPMorgan
Lennar price target lowered to $127 from $143 at JPMorgan
ABUS Arbutus Biopharma
$6.10 /

+2.9 (+90.63%)

11/08/21 H.C. Wainwright
Arbutus Biopharma price target lowered to $8 from $10 at H.C. Wainwright
06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
MRNA Moderna
$321.88 /

-30.82 (-8.74%)

11/28/21 Piper Sandler
Moderna has multiple booster candidates to combat omicron, says Piper Sandler
11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
CRM Salesforce
$265.97 /

-19.04 (-6.68%)

12/01/21 Jefferies
Salesforce promotion of Taylor to co-CEO a positive, says Jefferies
12/01/21 Morgan Stanley
Salesforce Q3 'likely fell short' of expectations, says Morgan Stanley
12/01/21 Truist
Salesforce price target raised to $330 from $315 at Truist
12/01/21 UBS
Salesforce price target lowered to $315 from $330 at UBS
XOM Exxon Mobil
$61.38 /

+1.58 (+2.64%)

11/02/21
Fly Intel: Top five analyst downgrades
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
10/21/21 Morgan Stanley
Exxon Mobil, Chevron look poised for 'catch up trade,' says Morgan Stanley
HPE HP Enterprise
$14.49 /

+0.11 (+0.76%)

12/01/21 Raymond James
HP Enterprise price target raised to $21 from $20 at Raymond James
12/01/21 Citi
Citi cuts HP Enterprise target, opens pair trade with NetApp
11/11/21 Goldman Sachs
HP Enterprise downgraded to Sell from Neutral at Goldman Sachs
10/06/21 Morgan Stanley
HP Enterprise price target lowered to $16 from $18 at Morgan Stanley
MRK Merck
$76.22 /

+1.36 (+1.82%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
ZS Zscaler
$327.43 /

-19.78 (-5.70%)

12/01/21 Truist
Zscaler price target raised to $400 from $325 at Truist
12/01/21 Wedbush
Zscaler price target raised to $400 from $320 at Wedbush
12/01/21 Canaccord
Zscaler price target raised to $400 from $340 at Canaccord
12/01/21 Needham
Zscaler price target raised to $418 from $390 at Needham
UNCRY UniCredit
$6.04 /

+0.072 (+1.21%)

11/25/21 Goldman Sachs
UniCredit reinstated with a Conviction Buy at Goldman Sachs
11/09/21 HSBC
UniCredit upgraded to Buy from Hold at HSBC
11/02/21 UBS
UniCredit price target raised to EUR 14.65 from EUR 14.45 at UBS
10/26/21 Societe Generale
UniCredit price target raised to EUR 12 from EUR 10.60 at Societe Generale
MCD McDonald's
$249.99 /

+5.47 (+2.24%)

11/16/21 Argus
Wendy's downgraded to Hold at Argus after miss on Q3 comps and margins
10/28/21 Credit Suisse
McDonald's price target raised to $281 from $271 at Credit Suisse
10/28/21 Oppenheimer
McDonald's price target raised to $280 from $270 at Oppenheimer
10/28/21 JPMorgan
McDonald's price target raised to $260 from $250 at JPMorgan
MSFT Microsoft
$338.11 /

+7.38 (+2.23%)

12/01/21 BMO Capital
UiPath price target lowered to $57 from $70 at BMO Capital
11/22/21 Wells Fargo
Wells Fargo starts Microsoft with Overweight, $400 target on 'bright future'
11/22/21 Wells Fargo
Microsoft initiated with an Overweight at Wells Fargo
11/19/21 UBS
Zoom Video price target lowered to $285 from $315 at UBS
STLA Stellantis
$18.00 /

+0.855 (+4.99%)

11/29/21 Citi
Stellantis resumed with a Buy at Citi
11/02/21 Nomura
Nomura downgrades Ford to Reduce, calls premium valuation 'hard to justify'
09/07/21 KeyBanc
Jeep micro site on Amazon points to auto sales moving online, says KeyBanc
09/03/21 Deutsche Bank
Stellantis deal 'significant opportunity' for Open Lending, says Deutsche Bank
ME 23andMe
$8.15 /

-0.03 (-0.37%)

11/14/21 Citi
23andMe downgraded to Neutral from Buy at Citi
08/16/21 Credit Suisse
23andMe initiated with an Outperform at Credit Suisse
08/16/21 Citi
23andMe price target lowered to $12 from $14 at Citi
07/13/21 Citi
23andMe initiated with a Buy at Citi
IMGN ImmunoGen
$7.10 /

+0.92 (+14.89%)

12/01/21 Jefferies
ImmunoGen upgraded to Buy at Jefferies after 'best-case data' in PROC
12/01/21 Jefferies
ImmunoGen upgraded to Buy from Hold at Jefferies
11/30/21 Piper Sandler
Piper says outlook on ImmunoGen's mirve opportunity 'largely unchanged'
11/30/21 RBC Capital
ImmunoGen price target raised to $9 from $8 at RBC Capital
BBW Build-A-Bear
$22.03 /

+5.14 (+30.43%)

GIII G-III Apparel
$30.60 /

+0.86 (+2.89%)

06/08/21 B. Riley
G-III Apparel price target raised to $41 from $39 at B. Riley
06/08/21 Barclays
G-III Apparel price target raised to $30 from $27 at Barclays
03/19/21 B. Riley
G-III Apparel price target raised to $38 from $33 at B. Riley Securities
03/19/21 Barclays
G-III Apparel price target raised to $27 from $24 at Barclays
BYSI BeyondSpring
$5.65 /

-7.11 (-55.72%)

12/01/21 William Blair
BeyondSpring cut to Market Perform at William Blair after CRL for plinabulin
12/01/21 William Blair
BeyondSpring downgraded to Market Perform from Outperform at William Blair
12/01/21 H.C. Wainwright
BeyondSpring downgraded to Neutral at H.C. Wainwright after CRL for plinabulin
12/01/21 H.C. Wainwright
BeyondSpring downgraded to Neutral from Buy at H.C. Wainwright
CTIC CTI BioPharma
$1.81 /

-0.425 (-19.02%)

12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
BIRD Allbirds
$16.44 /

-2.835 (-14.71%)

12/01/21 Morgan Stanley
Morgan Stanley says Allbirds investors may have been seeking upside
11/29/21
Fly Intel: Top five analyst initiations
11/29/21 Guggenheim
Guggenheim starts Allbirds at Buy, sees 50% potential upside
11/29/21 Guggenheim
Allbirds initiated with a Buy at Guggenheim
BOX Box
$26.30 /

+2.83 (+12.06%)

12/01/21 Craig-Hallum
Box price target raised to $38 from $31 at Craig-Hallum
12/01/21 Morgan Stanley
Box price target raised to $30 at Morgan Stanley after 'beat and raise quarter'
12/01/21 Raymond James
Box price target raised to $30 from $29 at Raymond James
10/07/21
Fly Intel: Top five analyst downgrades
GFS GlobalFoundries
$67.74 /

-1.68 (-2.42%)

12/01/21 Morgan Stanley
GlobalFoundries target up to $68 at Morgan Stanley after 'solid' first report
12/01/21 Credit Suisse
GlobalFoundries price target raised to $80 from $75 at Credit Suisse
12/01/21 Deutsche Bank
GlobalFoundries price target raised to $78 from $75 at Deutsche Bank
11/22/21
Fly Intel: Top five analyst initiations
AMBA Ambarella
$221.50 /

+41.59 (+23.12%)

12/01/21 Colliers
Ambarella price target raised to $245 from $135 at Colliers
12/01/21 Cowen
Ambarella price target raised to $235 from $150
12/01/21 Craig-Hallum
Ambarella price target raised to $250 from $170 at Craig-Hallum
12/01/21 Morgan Stanley
Ambarella price target raised to $229 from $222 at Morgan Stanley
CLS Celestica
$10.14 /

-0.09 (-0.88%)

09/23/21 Citi
Celestica price target raised to $8.50 from $8 at Citi
05/25/21 Stifel
Plexus warning may be signal that supply constraints will worsen, says Stifel
DNUT Krispy Kreme
$13.52 /

-0.99 (-6.82%)

12/01/21
Fly Intel: Top five analyst downgrades
12/01/21 Goldman Sachs
Krispy Kreme downgraded to Sell from Neutral at Goldman Sachs
11/08/21
Fly Intel: Top five analyst downgrades
11/08/21 Truist
Krispy Kreme downgraded to Hold from Buy at Truist
DASH DoorDash
$175.32 /

-3.44 (-1.92%)

12/01/21 Gordon Haskett
Gordon Haskett sees 'compelling re-entry point,' upgrades DoorDash to Buy
12/01/21 Gordon Haskett
DoorDash upgraded to Buy from Hold at Gordon Haskett
11/22/21 KGI Securities
DoorDash upgraded to Outperform from Neutral at KGI Securities
DHI D.R. Horton
$99.48 /

+1.74 (+1.78%)

12/01/21 Goldman Sachs
D.R. Horton downgraded to Neutral from Buy at Goldman Sachs
11/17/21 Raymond James
D.R. Horton price target raised to $120 from $110 at Raymond James
11/11/21 Citi
D.R. Horton price target raised to $116 from $104 at Citi
ZS Zscaler
$327.43 /

-19.78 (-5.70%)

XOM Exxon Mobil
$61.38 /

+1.58 (+2.64%)

STLA Stellantis
$18.00 /

+0.855 (+4.99%)

MSFT Microsoft
$338.11 /

+7.38 (+2.23%)

MRNA Moderna
$321.88 /

-30.82 (-8.74%)

MRK Merck
$76.22 /

+1.36 (+1.82%)

ME 23andMe
$8.15 /

-0.03 (-0.37%)

MCD McDonald's
$249.99 /

+5.47 (+2.24%)

LEN Lennar
$109.64 /

+4.58 (+4.36%)

IMGN ImmunoGen
$7.10 /

+0.92 (+14.89%)

HPE HP Enterprise
$14.49 /

+0.11 (+0.76%)

GIII G-III Apparel
$30.60 /

+0.86 (+2.89%)

GFS GlobalFoundries
$67.74 /

-1.68 (-2.42%)

DNUT Krispy Kreme
$13.52 /

-0.99 (-6.82%)

DHI D.R. Horton
$99.48 /

+1.74 (+1.78%)

DASH DoorDash
$175.32 /

-3.44 (-1.92%)

CTIC CTI BioPharma
$1.81 /

-0.425 (-19.02%)

CRM Salesforce
$265.97 /

-19.04 (-6.68%)

COF Capital One
$142.66 /

+2.165 (+1.54%)

CLS Celestica
$10.14 /

-0.09 (-0.88%)

BYSI BeyondSpring
$5.65 /

-7.11 (-55.72%)

BOX Box
$26.30 /

+2.83 (+12.06%)

BIRD Allbirds
$16.44 /

-2.835 (-14.71%)

BBW Build-A-Bear
$22.03 /

+5.14 (+30.43%)

AMBA Ambarella
$221.50 /

+41.59 (+23.12%)

ABUS Arbutus Biopharma
$6.10 /

+2.9 (+90.63%)

  • 02
    Dec
  • 03
    Nov
  • 28
    Oct
  • 19
    Aug
  • 01
    Jul
  • 20
    May
  • 01
    Apr
  • 09
    Dec
ZS Zscaler
$327.43 /

-19.78 (-5.70%)

XOM Exxon Mobil
$61.38 /

+1.58 (+2.64%)

UNCRY UniCredit
$6.04 /

+0.072 (+1.21%)

STLA Stellantis
$18.00 /

+0.855 (+4.99%)

MSFT Microsoft
$338.11 /

+7.38 (+2.23%)

MRNA Moderna
$321.88 /

-30.82 (-8.74%)

MRK Merck
$76.22 /

+1.36 (+1.82%)

ME 23andMe
$8.15 /

-0.03 (-0.37%)

MCD McDonald's
$249.99 /

+5.47 (+2.24%)

LEN Lennar
$109.64 /

+4.58 (+4.36%)

HPE HP Enterprise
$14.49 /

+0.11 (+0.76%)

DNUT Krispy Kreme
$13.52 /

-0.99 (-6.82%)

DHI D.R. Horton
$99.48 /

+1.74 (+1.78%)

DASH DoorDash
$175.32 /

-3.44 (-1.92%)

CRM Salesforce
$265.97 /

-19.04 (-6.68%)

COF Capital One
$142.66 /

+2.165 (+1.54%)

BOX Box
$26.30 /

+2.83 (+12.06%)

ZS Zscaler
$327.43 /

-19.78 (-5.70%)

XOM Exxon Mobil
$61.38 /

+1.58 (+2.64%)

UNCRY UniCredit
$6.04 /

+0.072 (+1.21%)

STLA Stellantis
$18.00 /

+0.855 (+4.99%)

MSFT Microsoft
$338.11 /

+7.38 (+2.23%)

MRNA Moderna
$321.88 /

-30.82 (-8.74%)

ME 23andMe
$8.15 /

-0.03 (-0.37%)

MCD McDonald's
$249.99 /

+5.47 (+2.24%)

LEN Lennar
$109.64 /

+4.58 (+4.36%)

HPE HP Enterprise
$14.49 /

+0.11 (+0.76%)

GIII G-III Apparel
$30.60 /

+0.86 (+2.89%)

GFS GlobalFoundries
$67.74 /

-1.68 (-2.42%)

DNUT Krispy Kreme
$13.52 /

-0.99 (-6.82%)

DHI D.R. Horton
$99.48 /

+1.74 (+1.78%)

DASH DoorDash
$175.32 /

-3.44 (-1.92%)

CRM Salesforce
$265.97 /

-19.04 (-6.68%)

COF Capital One
$142.66 /

+2.165 (+1.54%)

BYSI BeyondSpring
$5.65 /

-7.11 (-55.72%)

BOX Box
$26.30 /

+2.83 (+12.06%)

BIRD Allbirds
$16.44 /

-2.835 (-14.71%)

AMBA Ambarella
$221.50 /

+41.59 (+23.12%)

ABUS Arbutus Biopharma
$6.10 /

+2.9 (+90.63%)

ZS Zscaler
$327.43 /

-19.78 (-5.70%)

XOM Exxon Mobil
$61.38 /

+1.58 (+2.64%)

MSFT Microsoft
$338.11 /

+7.38 (+2.23%)

MRNA Moderna
$321.88 /

-30.82 (-8.74%)

MRK Merck
$76.22 /

+1.36 (+1.82%)

ME 23andMe
$8.15 /

-0.03 (-0.37%)

MCD McDonald's
$249.99 /

+5.47 (+2.24%)

LEN Lennar
$109.64 /

+4.58 (+4.36%)

HPE HP Enterprise
$14.49 /

+0.11 (+0.76%)

GFS GlobalFoundries
$67.74 /

-1.68 (-2.42%)

DNUT Krispy Kreme
$13.52 /

-0.99 (-6.82%)

DHI D.R. Horton
$99.48 /

+1.74 (+1.78%)

DASH DoorDash
$175.32 /

-3.44 (-1.92%)

CRM Salesforce
$265.97 /

-19.04 (-6.68%)

COF Capital One
$142.66 /

+2.165 (+1.54%)

BYSI BeyondSpring
$5.65 /

-7.11 (-55.72%)

BOX Box
$26.30 /

+2.83 (+12.06%)

BIRD Allbirds
$16.44 /

-2.835 (-14.71%)

AMBA Ambarella
$221.50 /

+41.59 (+23.12%)

ABUS Arbutus Biopharma
$6.10 /

+2.9 (+90.63%)

On The Fly
Fly Intel: Pre-market Movers » 09:15
12/01/21
12/01
09:15
12/01/21
09:15
XPEV

XPeng

$55.00 /

+3.64 (+7.09%)

, LI

Li Auto

$35.28 /

+0.8 (+2.32%)

, NIO

Nio

$39.19 /

-1.27 (-3.14%)

, GIII

G-III Apparel

$29.74 /

-1.21 (-3.91%)

, BBW

Build-A-Bear

$17.01 /

-0.02 (-0.12%)

, AMBA

Ambarella

$180.08 /

-1.835 (-1.01%)

, BIRD

Allbirds

$19.33 /

+0.5 (+2.66%)

, HPE

HP Enterprise

$14.38 /

-0.22 (-1.51%)

, DNUT

Krispy Kreme

$14.53 /

-0.68 (-4.47%)

, CTIC

CTI BioPharma

$2.23 /

-0.43 (-16.17%)

Check out this morning's…

ShowHide Related Items >><<
XPEV XPeng
$55.00 /

+3.64 (+7.09%)

NIO Nio
$39.19 /

-1.27 (-3.14%)

LI Li Auto
$35.28 /

+0.8 (+2.32%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

GIII G-III Apparel
$29.74 /

-1.21 (-3.91%)

DNUT Krispy Kreme
$14.53 /

-0.68 (-4.47%)

CTIC CTI BioPharma
$2.23 /

-0.43 (-16.17%)

BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

XPEV XPeng
$55.00 /

+3.64 (+7.09%)

11/24/21 BofA
XPeng price target raised to $66 from $63 at BofA
11/24/21 Citi
XPeng price target raised to $92 from $87 at Citi
11/11/21 Citi
XPeng price target raised to $87 from $53.40 at Citi
10/28/21
Fly Intel: Top five analyst initiations
LI Li Auto
$35.28 /

+0.8 (+2.32%)

11/11/21 Citi
Li Auto price target raised to $200 from $165 at Citi
10/28/21 Bernstein
Bernstein starts Li Auto at Outperform, sees EVs as 'future' of Chinese autos
10/28/21 Bernstein
Li Auto initiated with an Outperform at Bernstein
NIO Nio
$39.19 /

-1.27 (-3.14%)

11/23/21 Citi
Citi says Nio shares oversold after offering, keeps $87 target
11/11/21 Mizuho
Nio price target lowered to $65 from $67 at Mizuho
11/11/21 Citi
Nio price target raised to $87 from $70 at Citi
11/04/21 Deutsche Bank
Nio price target raised to $70 from $60 at Deutsche Bank
GIII G-III Apparel
$29.74 /

-1.21 (-3.91%)

06/08/21 B. Riley
G-III Apparel price target raised to $41 from $39 at B. Riley
06/08/21 Barclays
G-III Apparel price target raised to $30 from $27 at Barclays
03/19/21 B. Riley
G-III Apparel price target raised to $38 from $33 at B. Riley Securities
03/19/21 Barclays
G-III Apparel price target raised to $27 from $24 at Barclays
BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

12/01/21 Craig-Hallum
Ambarella price target raised to $250 from $170 at Craig-Hallum
12/01/21 Morgan Stanley
Ambarella price target raised to $229 from $222 at Morgan Stanley
12/01/21 Needham
Ambarella price target raised to $225 from $220 at Needham
12/01/21 Wells Fargo
Ambarella price target raised to $185 from $115 at Wells Fargo
BIRD Allbirds
$19.33 /

+0.5 (+2.66%)

12/01/21 Morgan Stanley
Morgan Stanley says Allbirds investors may have been seeking upside
11/29/21
Fly Intel: Top five analyst initiations
11/29/21 Guggenheim
Guggenheim starts Allbirds at Buy, sees 50% potential upside
11/29/21 Guggenheim
Allbirds initiated with a Buy at Guggenheim
HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

12/01/21 Raymond James
HP Enterprise price target raised to $21 from $20 at Raymond James
12/01/21 Citi
Citi cuts HP Enterprise target, opens pair trade with NetApp
11/11/21 Goldman Sachs
HP Enterprise downgraded to Sell from Neutral at Goldman Sachs
10/06/21 Morgan Stanley
HP Enterprise price target lowered to $16 from $18 at Morgan Stanley
DNUT Krispy Kreme
$14.53 /

-0.68 (-4.47%)

12/01/21 Goldman Sachs
Krispy Kreme downgraded to Sell from Neutral at Goldman Sachs
11/08/21
Fly Intel: Top five analyst downgrades
11/08/21 Truist
Krispy Kreme downgraded to Hold from Buy at Truist
11/08/21 Truist
Krispy Kreme downgraded to Hold from Buy at Truist
CTIC CTI BioPharma
$2.23 /

-0.43 (-16.17%)

12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
XPEV XPeng
$55.00 /

+3.64 (+7.09%)

NIO Nio
$39.19 /

-1.27 (-3.14%)

LI Li Auto
$35.28 /

+0.8 (+2.32%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

GIII G-III Apparel
$29.74 /

-1.21 (-3.91%)

DNUT Krispy Kreme
$14.53 /

-0.68 (-4.47%)

CTIC CTI BioPharma
$2.23 /

-0.43 (-16.17%)

BIRD Allbirds
$19.33 /

+0.5 (+2.66%)

BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

  • 03
    Nov
  • 13
    Aug
  • 01
    Jul
  • 01
    Apr
  • 14
    Dec
  • 09
    Dec
  • 04
    Dec
XPEV XPeng
$55.00 /

+3.64 (+7.09%)

NIO Nio
$39.19 /

-1.27 (-3.14%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

DNUT Krispy Kreme
$14.53 /

-0.68 (-4.47%)

XPEV XPeng
$55.00 /

+3.64 (+7.09%)

NIO Nio
$39.19 /

-1.27 (-3.14%)

LI Li Auto
$35.28 /

+0.8 (+2.32%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

GIII G-III Apparel
$29.74 /

-1.21 (-3.91%)

DNUT Krispy Kreme
$14.53 /

-0.68 (-4.47%)

BIRD Allbirds
$19.33 /

+0.5 (+2.66%)

BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

XPEV XPeng
$55.00 /

+3.64 (+7.09%)

NIO Nio
$39.19 /

-1.27 (-3.14%)

LI Li Auto
$35.28 /

+0.8 (+2.32%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

DNUT Krispy Kreme
$14.53 /

-0.68 (-4.47%)

BIRD Allbirds
$19.33 /

+0.5 (+2.66%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

Recommendations
CTI BioPharma delay creates buying opportunity, says Lake Street » 08:53
12/01/21
12/01
08:53
12/01/21
08:53
CTIC

CTI BioPharma

$2.23 /

-0.43 (-16.17%)

After CTI BioPharma…

After CTI BioPharma announced a three-month extension to the FDA review period for pacritinib, Lake Street analyst Thomas Flaten said he was "disappointed by the delay," but he does not believe it jeopardizes the approvability of pacritinib by the new assigned deadline of February 28, 2022. He views any weakness in shares as a buying opportunity and maintains a Buy rating and $15 price target on CTI shares.

ShowHide Related Items >><<
CTIC CTI BioPharma
$2.23 /

-0.43 (-16.17%)

CTIC CTI BioPharma
$2.23 /

-0.43 (-16.17%)

10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
05/06/21
Fly Intel: Top five analyst initiations
CTIC CTI BioPharma
$2.23 /

-0.43 (-16.17%)

  • 01
    Apr
Hot Stocks
CTI BioPharma announces extension of FDA review period for pacritinib NDA » 17:33
11/30/21
11/30
17:33
11/30/21
17:33
CTIC

CTI BioPharma

$2.23 /

-0.43 (-16.17%)

CTI BioPharma announced…

CTI BioPharma announced the FDA has extended the review period for the new drug application, or NDA, for pacritinib for the treatment of adult patients with intermediate or high-risk primary or secondary myelofibrosis, or MF. The Prescription Drug User Fee Act action date has been extended by three months to February 28, 2022. In Q2, the FDA granted priority review for CTI's NDA for patients with myelofibrosis with a PDUFA date of November 30. In the course of product labeling discussions, the FDA requested additional clinical data, which was submitted to the agency on November 24. Earlier, the FDA informed the company that it considers the data submission to constitute a "major amendment" to the NDA and therefore the PDUFA date has been extended by three months to provide additional time for a full review of the submission. At the current time, CTI is not aware of any major deficiencies in the application.

ShowHide Related Items >><<
CTIC CTI BioPharma
$2.23 /

-0.43 (-16.17%)

CTIC CTI BioPharma
$2.23 /

-0.43 (-16.17%)

10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
05/06/21
Fly Intel: Top five analyst initiations
CTIC CTI BioPharma
$2.23 /

-0.43 (-16.17%)

  • 01
    Apr
Conference/Events
FDA PDUFA Date for CTI BioPharma Pacritinib is November 30, 2021  04:55
11/30/21
11/30
04:55
11/30/21
04:55
CTIC

CTI BioPharma

$2.66 /

+0.18 (+7.26%)

 
ShowHide Related Items >><<
CTIC CTI BioPharma
$2.66 /

+0.18 (+7.26%)

CTIC CTI BioPharma
$2.66 /

+0.18 (+7.26%)

10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
05/06/21
Fly Intel: Top five analyst initiations
CTIC CTI BioPharma
$2.66 /

+0.18 (+7.26%)

  • 01
    Apr
Conference/Events
FDA PDUFA Date for CTI BioPharma Pacritinib is November 30, 2021  22:35
11/29/21
11/29
22:35
11/29/21
22:35
CTIC

CTI BioPharma

$2.66 /

+0.18 (+7.26%)

 
ShowHide Related Items >><<
CTIC CTI BioPharma
$2.66 /

+0.18 (+7.26%)

CTIC CTI BioPharma
$2.66 /

+0.18 (+7.26%)

10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
05/06/21
Fly Intel: Top five analyst initiations
CTIC CTI BioPharma
$2.66 /

+0.18 (+7.26%)

  • 01
    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.